Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
Phase 2 Recruiting
40 enrolled
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Phase 2 Recruiting
160 enrolled
MoonRISe-3
Phase 3 Recruiting
220 enrolled
Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies
Phase 1 Recruiting
60 enrolled
Phase II Trial of Lung Chemoemobolization
Phase 2 Recruiting
30 enrolled
HIPEC-PMP
Phase 3 Recruiting
176 enrolled
Adaptive Radiation in Anal Cancer
Phase NA Recruiting
20 enrolled
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Phase 3 Recruiting
486 enrolled
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Phase 3 Recruiting
70 enrolled
Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
Phase 2 Recruiting
100 enrolled
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Phase 1 Recruiting
49 enrolled
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
Phase 2 Recruiting
21 enrolled
COBRA-NMIBC
Phase 4 Recruiting
272 enrolled
In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial
Phase 1/2 Recruiting
40 enrolled
IMGeS
Phase 2 Recruiting
82 enrolled
KANALRAD
Phase 3 Recruiting
310 enrolled